Clinical Trials on Obese Patients With Non-alcoholic Steatohepatitis (NASH)
Total 0 results
Nothing found
Sponsors and Collaborators
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- Åke Wibergs Stiftelse
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- Hospitales Universitarios Virgen del Rocío
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- AlpinARC
- the people hospital of Linzhi
- Centro Universitário Franciscano
- Bassam Abdulkarim
- National Institute of Cardiovascular Diseases, Bangladesh
- Sahachat Aueyingsak
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- Sublimity Therapeutics Holdco Limited
- Glasgow Western Infirmary
- Daniela Pacella - University of Naples Federico II, Naples
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- Etan Orgel
- ECMC
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- Dr Philippe METELLUS
- View Full List
Medical Conditions
- Degenerative Spondylolisthesis G1
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Panniculectomy
- Legal History
- Value-Based Health Insurance
- Transitional Cell Carcinoma of Renal Pelvis
- Hyperprolinemia
- Initiation of Depo-Provera (DMPA)
- Orthopaedic Disorders
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Eosinophil Blood Count
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Progression to PD-1 Antibody
- Ability to Swim 100m Independent Freestyle
- Genetic Risk Factor
- Patients With Leptomeningeal Disease
- Pancreaticoduodenectomy
- Interviews
- View Full List
Drug Interventions
- Omeprazole 20mg
- Antibiotic treatment
- IV rtPA (intravenous recombinant plasminogen activator)
- Erythropoietin
- Injectable Insulin
- Gefitinib
- 6% hetastarch
- 0% N2O
- Epirubicin hydrochloride
- ASP8062
- Mepivacaine
- Paliperidone palmitate
- Metoclopramide + dexamethasone
- Prasugrel
- Cefuroxime 750mg oral
- 5-Fluoro-uracil
- Nimotuzumab
- UFUR and Iressa
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- HBM4003 and Triprilimab
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Chile
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mali
- Contract Research Organizations in Norway
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Slovenia
- Contract Research Organizations in South Africa
- Contract Research Organizations in South Korea
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Thailand
- Contract Research Organizations in Tunisia
- CRO list by country